Chan Errol Wei'en, Li Xiang, Tham Yih-Chung, Liao Jiemin, Wong Tien Yin, Aung Tin, Cheng Ching-Yu
Department of Ophthalmology, National University of Singapore and National University Health System, Singapore, Singapore.
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, USA Duke-NUS Graduate Medical School, Singapore, Singapore.
Br J Ophthalmol. 2016 Jan;100(1):78-85. doi: 10.1136/bjophthalmol-2014-306102. Epub 2015 Jun 25.
To evaluate glaucoma prevalence and disease burden across Asian subregions from 2013 to 2040.
We conducted a systematic review and meta-analysis of 23 population-based studies of 1318 primary open angle glaucoma (POAG) cases in 66,800 individuals and 691 primary angle closure glaucoma (PACG) cases in 72,767 individuals in Asia. Regions in Asia were defined based on United Nations' (UN) classification of macro-geographic regions. PubMed, Medline and Web of Science databases were searched for population-based glaucoma prevalence studies using standardised criteria published to 31 December 2013. Pooled glaucoma prevalence for individuals aged 40-80 years was calculated using hierarchical Bayesian approaches. Prevalence differences by geographic subregion, subtype and habitation were examined with random effects meta-regression models. Estimates of individuals with glaucoma from 2013 to 2040 were based on the UN World Population Prospects.
In 2013, pooled overall glaucoma prevalence was 3.54% (95% credible interval (CrI) 1.83 to 6.28). POAG (2.34%, 95% CrI 0.96 to 4.55) predominated over PACG (0.73%, 95% CrI 0.18 to 1.96). With age and gender adjustment, PACG prevalence was higher in East than South East Asia (OR 5.55, 95% CrI 1.52 to 14.73), and POAG prevalence was higher in urban than rural populations (OR 2.11, 95% CrI 1.57 to 2.38). From 2013 to 2040, South Central Asia will record the steepest increase in number of glaucoma individuals from 17.06 million to 32.90 million compared with other Asian subregions. In 2040, South-Central Asia is also projected to overtake East Asia for highest overall glaucoma and POAG burden, while PACG burden remains highest in East Asia.
Across the Asian subregions, there was greater glaucoma burden in South-Central and East Asia. Sustainable public health strategies to combat glaucoma in Asia are needed.
评估2013年至2040年亚洲各次区域的青光眼患病率和疾病负担。
我们对23项基于人群的研究进行了系统评价和荟萃分析,这些研究涉及亚洲66800人中的1318例原发性开角型青光眼(POAG)病例以及72767人中的691例原发性闭角型青光眼(PACG)病例。亚洲的区域是根据联合国对宏观地理区域的分类来定义的。使用截至2013年12月31日发布的标准化标准,在PubMed、Medline和科学网数据库中检索基于人群的青光眼患病率研究。采用分层贝叶斯方法计算40至80岁个体的合并青光眼患病率。使用随机效应荟萃回归模型检查地理次区域、亚型和居住情况的患病率差异。2013年至2040年青光眼患者人数的估计基于联合国《世界人口展望》。
2013年,合并的总体青光眼患病率为3.54%(95%可信区间(CrI)为1.83至6.28)。原发性开角型青光眼(2.34%,95%CrI为0.96至4.55)比原发性闭角型青光眼(0.73%,95%CrI为0.18至1.96)更为常见。经过年龄和性别调整后,东亚原发性闭角型青光眼的患病率高于东南亚(比值比5.55,95%CrI为1.52至14.73),原发性开角型青光眼的患病率城市高于农村人口(比值比2.11,95%CrI为1.57至2.38)。从2013年到2040年,与其他亚洲次区域相比,中亚南部青光眼患者人数的增长最为显著,将从1706万增加到3290万。预计到2040年,中亚南部在总体青光眼和原发性开角型青光眼负担方面也将超过东亚,而原发性闭角型青光眼负担在东亚仍然最高。
在亚洲各次区域中,中亚南部和东亚的青光眼负担较重。需要制定可持续的公共卫生策略来对抗亚洲的青光眼。